Omega 3 fatty acids for the treatment of dementia

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 3, 2015, Pages

  Burckhardt, Marion ^a   Herke, Max ^a   Wustmann, Tobias ^a   Watzke, Stefan ^a   Langer, Gero ^a   Fink, Astrid ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

OMEGA 3 FATTY ACID;

ARTICLE; CLINICAL EFFECTIVENESS; DEMENTIA; DIET SUPPLEMENTATION; HUMAN; INTERVENTION STUDY; MENTAL PERFORMANCE; NERVE CELL PLASTICITY; PATIENT SAFETY; PRIORITY JOURNAL; SYSTEMATIC REVIEW; THERAPY EFFECT; TREATMENT OUTCOME;

EID: 84962844373     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD009002.pub2     Document Type: Article

References (56)

1. American Psychiatric Association. Diagnostic and StatisticalManual of Mental Disorders [American Psychiatric Association, 1987.]. Diagnostic and Statistical Manual of Mental Disorders. 3rd Edition. Washington D.C.: American Psychiatric Association, 1987.
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th Edition. Washington D.C.: American Psychiatric Association, 1994.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th Edition. Arlington, VA: American Psychiatric Publishing, 2013.
4. Aranceta J, Perez-Rodrigo C. Recommended dietary reference intakes, nutritional goals and dietary guidelines for fat and fatty acids: a systematic review. British Journal of Nutrition 2012;107 Suppl 2:S8-22.
5. Arterburn LM, Hall EB, Oken H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. American Journal of Clinical Nutrition 2006;83:1467S-76S.
6. Bailey RL, Gahche JJ, Miller PE, Thomas PR, Dwyer JT. Why US adults use dietary supplements. JAMA International Medicine 2013;173:355-61.
7. Barnard ND, Bush AI, Ceccarelli A, Cooper J, de Jager CA, Erickson KI, et al. Dietary and lifestyle guidelines for the prevention of Alzheimers disease. Neurobiology of Aging 2014;35:S74-8.
8. Bråne G, Gottfries CG, Winblad B. The Gottfries-Bråne-Steen scale: validity, reliability and application in anti-dementia drug trials. Dementia and Geriatric Cognitive Disorders 2001;12:1-14.
9. Campbell A, Price J, Hiatt WR. Omega-3 fatty acids for intermittent claudication. Cochrane Database of Systematic Reviews 2013, Issue 7. [DOI: ]
10. Cansev M, Wurtman RJ, Sakamoto T, Ulus IH. Oral administration of circulating precursors for membrane phosphatides can promote the synthesis of new brain synapses. Alzheimer's & Dementia 2008;4:S153-68.
11. Cole GM, Ma QL, Frautschy SA. Omega-3 fatty acids and dementia. Prostaglandins, Leukotrienes, and Essential Fatty Acids 2009;81:213-21.
12. Deeks JJ, Higgins JPT, Altman DG (editors). Chapter 9: Analysing data and undertaking meta-analyses. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
13. Dickinson A, Blatman J, El-Dash N, Franco JC. Consumer usage and reasons for using dietary supplements: report of a series of surveys. Journal of the American College of Nutrition 2014;33:176-82.
14. EFSA Panel on Dietetic Products, Nutrition, Allergies (NDA). Scientific Opinion on Dietary Reference Values for fats, including saturated fatty acids, polyunsaturated fatty acids, monounsaturated fatty acids, trans fatty acids, and cholesterol. EFSA Journal 2010;8(3):1461. [DOI: ]
15. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
16. Thomson Reuters. EndNote X5. Thomson Reuters, 2011.
17. Food, Agriculture Organization of the United Nations (FAO). Fats and fatty acids in human nutrition. Report of an expert consultation.10-14 November 2008, Geneva. FAO Food and Nutrition Paper 91. Rome, 2010:188. [: ISBN 978-92-5-106733-8]
18. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975;12:189-98.
19. Galasko D, Bennett D, Sano M, Ernesto C, Thomas R, Grundman M, et al. An inventory to assess activities of daily living for clinical trials in Alzheimer's disease. The Alzheimer's Disease Cooperative Study. Alzheimer Disease & Associated Disorders 1997;11(Suppl 2):33-9.
20. Guyatt GH, Oxman AD, Kunz R, Atkins D, Brozek J, Vist G, et al. GRADE guidelines: 2. Framing the question and deciding on important outcomes. Journal of Clinical Epidemiology 2011;64(4):395-400.
21. Higgins JPT, Deeks JJ (editors). Chapter 7: Selecting studies and collecting data. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
22. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
23. Hooper L, Thompson RL, Harrison RA, Summerbell CD, Moore H, Worthington HV, et al. Omega 3 fatty acids for prevention and treatment of cardiovascular disease. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: ]
24. Institute for Qality and Efficiency in Health Care (IQWIG). Positronenemissionstomographie (PET) und PET/CT bei Alzheimer-Demenz. Berichtsplan Version 1.0. Available from www.iqwig.de. Köln: Institute for Quality and Efficiency in Health Care, 2013.
25. Larson EB, Yaffe K, Langa KM. New insights into the dementia epidemic. New England Jourlnal of Medicine 2013;369:2275-7.
26. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JPA, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Journal of Clinical Epidemiology 2009;62(10):e1-34.
27. Lopes da Silva S, Vellas B, Elemans S, Luchsinger J, Kamphuis P, Yaffe K, et al. Plasma nutrient status of patients with Alzheimer's disease: systematic review and meta-analysis. Alzheimer's & Dementia 2013;10(4):485-502.
28. McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CRJ, Kawas CH, et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimer's & Dementia 2011;7:263-9.
29. Micha R, Khatibzadeh S, Shi P, Fahimi S, Lim S, Andrews KG, et al. Global, regional, and national consumption levels of dietary fats and oils in 1990 and 2010: a systematic analysis including 266 country-specific nutrition surveys. BMJ 2014;348:g2272.
30. Molfino A, Gioia G, Fanelli FR, Muscaritoli M. The role for dietary omega-3 fatty acids supplementation in older adults. Nutrients 2014;6:4058-72.
31. Molnar FJ, Man-Son-Hing M, Fergusson D. Systematic review of measures of clinical significance employed in randomized controlled trials of drugs for dementia. Journal of the American Geriatrics Society 2009;57:536-46.
32. Morris MC, Tangney CC. Dietary fat composition and dementia risk. Neurobiology of Aging 2014;35 Suppl 2:S59-64.
33. Murphy T, Dias GP, Thuret S. Effects of diet on brain plasticity in animal and human studies: mind the gap. Neural Plasticity 2014:Article ID 563160.
34. O'Bryant SE, Waring SC, Cullum CM, Hall J, Lacritz L, Massman PJ, et al. Staging dementia using Clinical Dementia Rating Scale Sum of Boxes scores: a Texas Alzheimer's Research Consortium study. Archives of Neurology 2008;65(8):1091-5.
35. Reed B, Villeneuve S, Mack W, DeCarli C, Chui HC, Jagust W. Associations between serum cholesterol levels and cerebral amyloidosis. JAMA Neurology 2014;71:195-200.
36. Reuther S, van Nie N, Meijers J, Halfens R, Bartholomeyczik S. Malnutrition and dementia in the elderly in German nursing homes. Results of a prevalence survey from the years 2008 and 2009 [Mangelernahrung und Demenz bei Bewohnern in Einrichtungen der stationaren Altenpflege in Deutschland]. Zeitschrift für Gerontologie und Geriatrie 2013;46:260-7.
37. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
38. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993;43(2):250-60.
39. Roque M, Salva A, Vellas B. Malnutrition in community-dwelling adults with dementia (NutriAlz Trial). Journal of Nutrition, Health and Aging 2013;17:295-9.
40. Rosen WG, Mohs RC, Davis KL. A new rating scale for Alzheimer's disease. American Journal of Psychiatry 1984;141:1356-64.
41. Schmidt M. Rey Auditory Verbal Learning Test™ (RAVLT™). A Handbook. http://www.wpspublish.com/app/ 1996.
42. Schneider LS, Olin JT, Doody RS, Clark CM, Morris JC, Reisberg B, et al. Validity and reliability of the Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change. The Alzheimer's Disease Cooperative Study. Alzheimer Disease and Associated Disorders 1997;11 Suppl 2:S22-32.
43. Schrag A, Schott JM, Alzheimer's Disease Neuroimaging Initiative. What is the clinically relevant change on the ADAS-Cog?. Journal of Neurology, Neurosurgery and Psychiatry 2012;83:171-3.
44. Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and Summary of findings' tables. In: Higgins JPT, Green S (editors), Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
45. Su HM. Mechanisms of n-3 fatty acid-mediated development and maintenance of learning memory performance. Journal of Nutritional Biochemistry 2010;21:364-73.
46. Sydenham E, Dangour AD, Lim W-S. Omega 3 fatty acid for the prevention of cognitive decline and dementia. Cochrane Database of Systematic Reviews 2012, Issue 6. [DOI: ]
47. United Nations Department of Economic and Social Affairs Population Division. World Population Ageing 2013. http://www.un.org/en/development/desa/population/publications/ (accessed 10 June 2014).
48. US Preventive Task Force. Screening for Cognitive Impairment in Older Adults: Final Recommendation Statement. AHRQ Publication No. 14-05198-EF-2. http://www.uspreventiveservicestaskforce.org/uspstf14/dementia/dementiafinalrs.htm 2014.
49. Vedin I, Cederholm T, Freund-Levi Y, Basun H, Garlind A, Irving GF, et al. Effects of DHA-rich n-3 fatty acid supplementation on gene expression in blood mononuclear leukocytes: the OmegAD study. PLoS One 2012;7:e35425.
50. Vellas B, Lauque S, Gillette-Guyonnet S, Andrieu S, Cortes F, Nourhashemi F, et al. Impact of nutritional status on the evolution of Alzheimer's disease and on response to acetylcholinesterase inhibitor treatment. Journal of Nutrition, Health and Aging 2005;9:75-80.
51. Vellas B, Andrieu S, Sampaio C, Coley N, Wilcock G. Endpoints for trials in Alzheimer's disease: a European task force consensus. Lancet Neurology 2008;7:436-50.
52. Wechsler D. - Fourth UK Edition (WMS-IV UK). Wechsler Memory Scale. Fourth UK Edition (WMS-IV UK). Pearson, 2010.
53. World Health Organization. The ICD-10 classification of mental and behavioural disorders: clinical description and diagnostic guidelines. Genevy: World Health Organization, Division of Mental Health, 1992.
54. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, 10th revision. Geneva: World Health Organization, 2010.
55. World Health Organization, Alzheimer's Disease International. Dementia. A Public Health Priority. Available from www.who.int/mental_health/publications/dementia_report_2012/en/ 2012. [: ISBN 978 92 4 156445 8]
56. Dionisi Fabiola, Calder Philip C. Omega 3 fatty acids for the treatment of dementia and cognitive impairment. Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2011. [DOI: ]